Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 27,416 | 10,277 | -19,595 | -55,744 | -40,955 |
| Depreciation Amortization | 3,418 | 2,212 | 1,058 | 3,320 | 2,232 |
| Accounts receivable | -1,185 | 1,196 | -2,781 | -3,809 | -5,042 |
| Accounts payable and accrued liabilities | -716 | -1,969 | 0 | 2,253 | 1,477 |
| Other Working Capital | -13,672 | -2,882 | -2,892 | -23,264 | -21,031 |
| Other Operating Activity | -64,184 | -40,068 | 5,476 | 12,221 | 11,452 |
| Operating Cash Flow | $-48,923 | $-31,234 | $-18,734 | $-65,023 | $-51,867 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,504 | -2,529 | -763 | -3,481 | -1,432 |
| Purchase Of Investment | -113,999 | -91,270 | -3,600 | -196,226 | -191,717 |
| Sale Of Investment | 104,300 | 78,300 | 46,000 | 148,576 | 134,076 |
| Investing Cash Flow | $-15,203 | $-15,499 | $41,637 | $-51,131 | $-59,073 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 25,000 | 25,000 | N/A | N/A |
| Debt Repayment | -10,000 | -10,000 | -10,000 | -5,000 | -3,500 |
| Common Stock Issued | 172 | 98,102 | 56 | 180 | 133 |
| Other Financing Activity | 109,221 | -5,981 | 646 | 636 | 963 |
| Financing Cash Flow | $124,393 | $107,121 | $15,702 | $-4,184 | $-2,404 |
| Beginning Cash Position | 4,975 | 4,975 | 4,975 | 125,313 | 125,313 |
| End Cash Position | 65,242 | 65,363 | 43,580 | 4,975 | 11,969 |
| Net Cash Flow | $60,267 | $60,388 | $38,605 | $-120,338 | $-113,344 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,923 | -31,234 | -18,734 | -65,023 | -51,867 |
| Capital Expenditure | -5,504 | -2,529 | -763 | -3,481 | -1,432 |
| Free Cash Flow | -54,427 | -33,763 | -19,497 | -68,504 | -53,299 |